ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 45 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,773,000 | -12.5% | 1,750,000 | -6.7% | 0.00% | – |
| Q4 2020 | $2,026,000 | -11.9% | 1,875,000 | -15.7% | 0.00% | – |
| Q3 2020 | $2,300,000 | +33.7% | 2,225,000 | +42.6% | 0.00% | – |
| Q2 2020 | $1,720,000 | +38.7% | 1,560,000 | +27.3% | 0.00% | – |
| Q1 2020 | $1,240,000 | +35.5% | 1,225,000 | +53.1% | 0.00% | – |
| Q4 2019 | $915,000 | -59.9% | 800,000 | -60.0% | 0.00% | – |
| Q3 2019 | $2,281,000 | +11.8% | 2,000,000 | +15.9% | 0.00% | – |
| Q2 2019 | $2,040,000 | -12.5% | 1,725,000 | 0.0% | 0.00% | – |
| Q1 2019 | $2,332,000 | +36.2% | 1,725,000 | +7.8% | 0.00% | – |
| Q4 2018 | $1,712,000 | +30.4% | 1,600,000 | +28.0% | 0.00% | – |
| Q3 2018 | $1,313,000 | +37.1% | 1,250,000 | +28.2% | 0.00% | – |
| Q2 2018 | $958,000 | -37.4% | 975,000 | -37.1% | 0.00% | – |
| Q1 2018 | $1,531,000 | -28.1% | 1,550,000 | -23.2% | 0.00% | – |
| Q4 2017 | $2,129,000 | -0.0% | 2,017,000 | 0.0% | 0.00% | – |
| Q3 2017 | $2,130,000 | +180.3% | 2,017,000 | +181.3% | 0.00% | – |
| Q2 2017 | $760,000 | +57.7% | 717,000 | +43.4% | 0.00% | – |
| Q1 2017 | $482,000 | – | 500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|